| Warcoma vs Reina | 51–31 | 62.20% |
| Warcoma vs Kazuya | 50–26 | 65.79% |
| Warcoma vs Bryan | 41–24 | 63.08% |
| Warcoma vs King | 36–28 | 56.25% |
| Warcoma vs Jin | 31–26 | 54.39% |
| Warcoma vs Dragunov | 25–29 | 46.30% |
| Warcoma vs Steve | 28–23 | 54.90% |
| Warcoma vs Leroy | 33–17 | 66.00% |
| Warcoma vs Paul | 27–20 | 57.45% |
| Warcoma vs Law | 33–14 | 70.21% |
| Warcoma vs Yoshimitsu | 25–21 | 54.35% |
| Warcoma vs Heihachi | 26–20 | 56.52% |
| Warcoma vs Hwoarang | 19–21 | 47.50% |
| Warcoma vs Lili | 23–17 | 57.50% |
| Warcoma vs Azucena | 24–16 | 60.00% |
| Warcoma vs Lee | 14–24 | 36.84% |
| Warcoma vs Victor | 15–23 | 39.47% |
| Warcoma vs Nina | 17–18 | 48.57% |
| Warcoma vs Asuka | 21–12 | 63.64% |
| Warcoma vs Devil Jin | 22–10 | 68.75% |
| Warcoma vs Leo | 14–17 | 45.16% |
| Warcoma vs Jun | 17–12 | 58.62% |
| Warcoma vs Claudio | 14–14 | 50.00% |
| Warcoma vs Xiaoyu | 17–7 | 70.83% |
| Warcoma vs Jack-8 | 11–13 | 45.83% |
| Warcoma vs Lars | 12–12 | 50.00% |
| Warcoma vs Raven | 12–12 | 50.00% |
| Warcoma vs Lidia | 18–5 | 78.26% |
| Warcoma vs Alisa | 16–6 | 72.73% |
| Warcoma vs Zafina | 13–5 | 72.22% |
| Warcoma vs Clive | 6–12 | 33.33% |
| Warcoma vs Shaheen | 9–7 | 56.25% |
| Warcoma vs Kuma | 9–7 | 56.25% |
| Warcoma vs Eddy | 5–11 | 31.25% |
| Warcoma vs Feng | 10–3 | 76.92% |
| Warcoma vs Panda | 7–3 | 70.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.